Concepedia

Rita Ruijter

RR

11

Publications

1K

Citations

11

H-Index

2002

Active since

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

Vrije Universiteit Amsterdam

Rita Ruijter is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in oncology, medicine, and radiation oncology.

Top concepts

Publications per year

2002–2018

11

Publications

11

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

Giuseppe Giaccone, Cornelis J. A. Punt, Rita Ruijter et al. · PubMed · 2002 · 507 citations

Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

Bart C. Kuenen, Lee S. Rosen, Egbert F. Smit et al. · Journal of Clinical Oncology · 2002 · 128 citations

, , +10

Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic Carcinomas

Giuseppe Giaccone, Arun Rajan, Rita Ruijter et al. · Journal of Thoracic Oncology · 2009 · 112 citations · Full text

, , +7

A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies

Bart C. Kuenen, Petronella O. Witteveen, Rita Ruijter et al. · Clinical Cancer Research · 2010 · 86 citations · Full text

Dose-Finding Study of the Multitargeted Tyrosine Kinase Inhibitor SU6668 in Patients with Advanced Malignancies

Bart C. Kuenen, Giuseppe Giaccone, Rita Ruijter et al. · Clinical Cancer Research · 2005 · 44 citations · Full text

Rows per page

1–5 of 11